Bristol-Myers Squibb Co. (BMY) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $62.86 +2.21%
Revenue Growth %: +3.4%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +3.4%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q2 EPS of $0.48, $0.01 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $4.44 billion versus the consensus estimate of $4.44 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- KLX Energy narrows Q3 2026 revenue guidance, completes rights offering
- Moody’s upgrades Brinker to Ba1 on Chili’s growth and debt reduction
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
